HIGHLIGHTS
- who: Jamir Pitton Rissardo and Ana Letu00edcia Fornari Caprara from the Medicine Department, Federal University of Santa Maria, Santa Maria, Brazil have published the paper: Gepants for Acute and Preventive Migraine Treatment: A Narrative Review, in the Journal: (JOURNAL)
- what: Gepants were the first oral agents specifically designed to prevent migraine.
- how: The authors hypothesized withdrawal of the studies with gepants lasmiditan and triptans did not show any relation that the more common central nervous system side effects related to ubrogepant were to the adverse effects.
- future: Studies including oral administration . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.